Skip to main content

Los Angeles Convention Center - Honda Super Meet

Friday, Jul 28

LOS ANGELES CONVENTION CENTER
1201 S FIGUEROA ST
LOS ANGELES, CA
90015

”THE FIRST AND ONLY OF IT’S KIND - AN INDUSTRY TRADE CONSUMER EVENT FOR ALL HONDA AND ACURA ORIENTED ENTHUSIASTS”
BUILDERS / MANUFACTURERS / RETAILERS / INFLUENCERS / RACERS / TUNERS
LET’S CONNECT - LET’S TALK!

——————

SUNDAY JULY 30, 2023
12PM-6PM

——————

GENERAL ADMISSION - $30.00 USD + SERVICE FEES (PRE-SALE ONLINE) // $40.00 USD + SERVICE FEES (DAY OF SHOW)
(KIDS FREE UNDER 12 W/ ACCOMPANIED ADULT)

——————-

SHOW REGISTRATION - $95.00 USD + SERVICE FEES *** SOLD OUT ***
(INCLUDES: 1 DRIVER PASS + TSHIRT + DECAL)
*** LIMITED SPACE AVAILABLE ***
*** SEMI MODIFIED VEHICLES ***

——————

VIP SHOW REGISTRATION - $95.00 USD + SERVICE FEES *** SOLD OUT ***
(INCLUDES: 1 DRIVER PASS + TSHIRT + DECAL)
*** LIMITED TO TOP/100 ONLY ***
*** HEAVY MODIFIED VEHICLES ONLY ***

——————

VENDOR REGISTRATION - $950.00 USD + SERVICE FEES
10x10 BOOTH SPACE
(INCLUDES: 4 VENDOR PASS + 1 BOOTH CAR)
*** A COMPANY PRINTED TENT WITH LOGO IS REQUIRED FOR DISPLAY (IF USING A TENT SETUP) ***
*** ALL BOOTH SETUP MUST BE APPROVED ***

——————

THIS IS A PRE-REGISTERED EVENT AND ALL SHOW VEHICLES MUST BE APPROVED FOR ENTRY INTO THE SHOW.
FIRST COME FIRST SERVED BASIS. WE RESERVED THE RIGHT TO REFUSE ANY UNFIT VEHICLE.

Event Information

  • Website:
    Visit Website

Get The News In Your Email Inbox Mondays & Thursdays


Featured CityWatch Stories

WESTSIDE - Currently larger than 40 states in terms of population with roughly 10 million residents, Los Angeles County…
Yom Kippur demands more than personal repentance. At a defining moment for Jews everywhere, it asks whether we have tru…
LA TRANSPO - For anyone traversing the San Fernando Valley, one thing is becoming increasingly clear: Los Angeles is sp…
GELFAND’S WORLD - The silly squabble that Donald Trump has provoked with Canada is now about to claim even more victims…
MY THOUGHTS - California’s SB 1094 could lower spending by expanding the use of biosimilars. But patients who have fina…